1 Growth Stock Down 47% to Buy Right Now

Ladies and gentlemen, listen up! We've got a golden opportunity here, and you don't want to miss it. The market's been a rollercoaster, but one stock has taken a nosedive that's too good to ignore. Rentokil Initial, a name you might not know, but trust me, it's a hidden gem. This stock is down 47% from its fair value, and it's time to scoop it up before the rest of the market catches on.

Let's break it down. Growth stocks have been on a wild ride. They were the darlings of 2024, outperforming value stocks by around 10 percentage points. But then came the selloffs, and growth stocks took a hit. The DeepSeek scare in January sent AI stocks tumbling over 20%, and the entire growth category followed suit. Now, growth stocks are trading close to fair value, but value stocks remain at a greater discount. This is your chance to get in on the ground floor of a company that's poised for a comeback.

Rentokil Initial is a standout in the specialty business services industry. They're the market leader in pest control and hygiene services, and they've been on an acquisition spree since 2015. Over 200 acquisitions later, they're a force to be reckoned with. The late-2022 acquisition of Terminix Global Holdings was a game-changer, creating a new US market share leader. This company knows how to execute, and their mergers-and-acquisitions strategy has delivered a durable cost advantage for their pest-control business.

Now, let's talk numbers. Rentokil Initial is trading at a 47% discount to its fair value estimate of $40.30 per share. That's right, folks, a 47% discount! This is a no-brainer. The stock has a Morningstar Uncertainty Rating of Medium and a Morningstar Capital Allocation Rating of Exemplary. They're in the growth portion of the Morningstar Style Box, and they're on Morningstar’s list of the Best Companies to Own for 2025. This is a company with a wide Morningstar Economic Moat Rating, predictable cash flows, and a management team that makes smart capital-allocation decisions.

But why the sudden drop? The market's been spooked by economic indicators. Elevated Treasury bond yields, a strong U.S. dollar, slow money-supply growth, and rising inflation have all contributed to a slowing growth environment. The 10-year bond rate peaked at 4.8% in mid-January, and considering the three-month lag effect, U.S. economic momentum may continue slowing until sometime in April. This has led to a stock-market decline, and growth stocks have been hit hard.

Investor sentiment is mixed, and the market hasn't turned bearish enough to be a contrarian buy signal. But that's okay, because we're not following the herd. We're buying when others are selling, and that's how you make money in this game.

So, what are you waiting for? Rentokil Initial is a growth stock down 47% to buy right now. This is your chance to get in on a company that's poised for a comeback. Don't miss out on this opportunity. BUY NOW!